ESPINOZA OCTAVIO (Chief Financial Officer) received a stock award from LIGAND PHARMACEUTICALS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/27/2026ACC: 0002001011-26-000035
Officer· Chief Financial Officer
Since Mar 2026
+28.46K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
28.46K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+4.93K
Price / share
—
Trade value
—
% of position
14.9%
3/2/2026
33.01K→37.95K
Total
Net shares
+4.93K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/2/2026 | A · Award | +4.93K | — | — | 14.9% | 33.01K | 37.95K |
| Total | +4.93K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
23.53K shares
Shares
+23.53K
Strike price
202.55
Held after
23.53K
Exercisable
—
3/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock23.53K shares | 3/2/2026 | A · Award | +23.53K | 202.55 | — | 23.53K |